<DOC>
	<DOCNO>NCT00522678</DOCNO>
	<brief_summary>GW685698X novel glucocorticoid receptor agonist develop orally inhale treatment asthma . In previous study inhale GW685698X administer dry powder contain either lactose alone lactose cellobiose octaacetate . However , future dry powder GW685698X formulation contain lactose magnesium stearate . This study first administration new GW685698X dry powder formulation man provide safety tolerability data support development formulation .</brief_summary>
	<brief_title>Repeat Dose GW685698X With Magnesium Stearate , Excipient Bridging Study , In Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy Volunteers , Aged 1865 Male female ( female nonchild bear potential meet contraception criterion ) . BMI 1931 kg/m2 History breathing problem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>